Clinical trialNCT03669614UnknownPhase 1/PHASE2Interventional

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

SponsorAridis Pharmaceuticals, Inc.Enrollment102Cystic Fibrosis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alan H Cohen, MD
Aridis Pharmaceuticals, Inc.
Study Director
clinicaltrials.gov ↗
Hasan S Jafri, MD, FAAP
Aridis Pharmaceuticals, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Tucson, Arizona, United States
Recruiting
Research Site
Long Beach, California, United States
Recruiting
Research Site
Denver, Colorado, United States
Recruiting
Research Site
Gainesville, Florida, United States
Recruiting
Research Site
Hollywood, Florida, United States
Recruiting
Research Site
Miami, Florida, United States
Recruiting
Research Site
Orlando, Florida, United States
Recruiting
Research Site
Tampa, Florida, United States
Recruiting
Research Site
Chicago, Illinois, United States
Recruiting
Research Site
Iowa City, Iowa, United States
Recruiting
Research Site
Overland Park, Kansas, United States
Completed
Research Site
Louisville, Kentucky, United States
Recruiting
Research Site
Portland, Maine, United States
Recruiting
Research Site
Baltimore, Maryland, United States
Recruiting
Research Site
Detroit, Michigan, United States
Recruiting
Research Site
Omaha, Nebraska, United States
Recruiting
Research Site
New York, New York, United States
Recruiting
Research Site
Cleveland, Ohio, United States
Recruiting
Research Site
Columbus, Ohio, United States
Recruiting
Research Site
Oklahoma City, Oklahoma, United States
Recruiting
Research Site
Philadelphia, Pennsylvania, United States
Recruiting
Research Site
Tyler, Texas, United States
Recruiting
Research Site
Salt Lake City, Utah, United States
Recruiting
Research Site
Seattle, Washington, United States
Recruiting
Research Site
Spokane, Washington, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Dec 2018
Primary completion: 31 Jul 2023
Completion: 31 Jul 2023
Last update posted: 9 Mar 2023
Registered enrollment: 102
Registry id: NCT03669614

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.